Skip to headlines
clockwire Search
LIVE
Piastri set for grid penalty at Las Vegas Grand Prix SEALSQ signs LOI to acquire QuintessenceLabs; LAES shares gain Tourist tries Welsh cake in Cardiff and can't believe what happens next The 4.5-star JBL speaker I use every day is $100 off — and it’s the bassiest, loudest, and most energetic speaker I’ve ever owned I tested the new Marvel Comics app for a week — and it’s a big upgrade from Marvel Unlimited (but 3 things still hold it back) CMA approves Africa Eats cross-listing and new dividend ETF on NSE Sweden's Moderates overtake Social Democrats for first time in ten years Emma Barnett ‘learned a great deal’ at Radio 4’s Today as she teases new show Pakistan slashes nano-loan charges: APR cap cut from 274% to 90% Nearly 300,000 children abroad receive German benefits, sparking political backlash Waterford proposals set to close big gap between county finals and Munster campaign OJK calls for stronger regional coordination in ASEAN insurance sector Indian rupee ends flat after hitting seven-month high as firmer dollar offsets inflows Cartoons of the week Cartoons of the week
‹ Back to your news
US FDA Rejects Summit's China-Originated Lung Cancer Drug

MARKETS United StatesChina

US FDA Rejects Summit's China-Originated Lung Cancer Drug

Covered by 2 sources First reported · latest report

How each outlet tells it

NDTV Profit (IN) · private

US FDA Rejects Summit's China-Originated Lung Cancer Drug

US FDA Rejects Summit's China-Originated Lung Cancer Drug

The FDA issued a so-called Complete Response Letter saying that it can't approve Summit's application in its present form because the drug didn't help patients live longer in…

Read at NDTV Profit

Investing.com (GB) · private

Summit Therapeutics stock plunges after FDA rejects lung cancer drug

Summit Therapeutics stock plunges after FDA rejects lung cancer drug

Read at Investing.com